RxDoctor Payments DataLook up a doctor →

Leora Horn

Medical Oncology · Nashville, TNNPI 1487881041

Payments from drug & device makers

$2,599,222in general payments, 2019–2025

Across 497 payments — averaging $5229.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$464K
  • Boehringer Ingelheim Pharma GmbH & Co.kg$451K
  • AstraZeneca$335K
  • E.r. Squibb & Sons, L.L.C.$255K
  • EMD Serono, Inc.$254K
  • Incyte Corporation$224K
  • plus $617K from 17 others
$7,948in research payments, 2019–2025

Across 9 payments — averaging $883.13 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • F. Hoffmann-la Roche AG$8K

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,599,222 in reported general payments places this provider in the 85th percentile of 101 medical oncology providers in Tennessee.

See all medical oncology providers in Tennessee

Other medical oncology in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →